BioSpace News Archive

Mosaic ImmunoEngineering Inc. today announced the election of Robert A. Baffi, Ph.D., to Mosaic’s Board of Directors.

Sutro Biopharma, Inc. today announced that Chief Executive Officer, Bill Newell , will participate in two virtual investor conferences in June.

Newly created roles will support StrideBio’s operations across strategy, regulatory affairs, quality, and patient advocacy.

Enko is recognized for applying the latest drug discovery and development approaches from pharma to agriculture.

Codiak BioSciences, Inc. today announced the promotion of Sriram Sathyanarayanan, Ph.D.

Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, today announced the U.S. Food and Drug Administration’s (FDA) clearance of its Investigational New Drug (IND) application for JTX-1811, an anti-CCR8 antibody, for which Gilead Sciences, Inc

Reflect Scientific, Inc., a provider of diverse products and services for the biotechnology, pharmaceutical, and transportation industries, announced the effectiveness of its Registration Statement on Form 10, as amended.

Global Blood Therapeutics, Inc. has awarded approximately $450,000 to U.S. community-based organizations and institutions as part of the company’s 2021 Access to Excellent Care for Sickle Cell Patients (ACCEL) Grant Program.

Medical Vein Clinic is pleased to announce that Dr. Josh Trock has joined San Antonio’s leading vein treatment center as their Doctor of Physical Therapy and Lymphedema Specialist.

Amyris, Inc. (Nasdaq: AMRS), , today announced that it has executed a binding term sheet for the acquisition of award-winning, clean wellness company OLIKA Inc. (OLIKA)